Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2017 Feb 1;7:41257. doi: 10.1038/srep41257

Unraveling the cytotoxicity and metabolic pathways of binary natural deep eutectic solvent systems

Yves Paul Mbous 1,2, Maan Hayyan 1,3,a, Won Fen Wong 4, Chung Yeng Looi 5, Mohd Ali Hashim 1,2
PMCID: PMC5286504  PMID: 28145498

Abstract

In this study, the anticancer potential and cytotoxicity of natural deep eutectic solvents (NADESs) were assessed using HelaS3, PC3, A375, AGS, MCF-7, and WRL-68 hepatic cell lines. NADESs were prepared from choline chloride, fructose, or glucose and compared with an N,N-diethyl ethanolammonium chloride:triethylene glycol DES. The NADESs (98 ≤ EC50 ≥ 516 mM) were less toxic than the DES (34 ≤ EC50 ≥ 120 mM). The EC50 values of the NADESs were significantly higher than those of the aqueous solutions of their individual components but were similar to those of the aqueous solutions of combinations of their chief elements. Due to the uniqueness of these results, the possibility that NADESs could be synthesized intracellularly to counterbalance the cytotoxicity of their excess principal constituents must be entertained. However, further research is needed to explore this avenue. NADESs exerted cytotoxicity by increasing membrane porosity and redox stress. In vivo, they were more destructive than the DES and induced liver failure. The potential of these mixtures was evidenced by their anticancer activity and intracellular processing. This infers that they can serve as tools for increasing our understanding of cell physiology and metabolism. It is likely that we only have begun to comprehend the nature of NADESs.


The demand for “greener” solvents has led to the emergence of deep eutectic solvents (DESs). A notable feature of DESs is their melting points, which are typically lower than the freezing points of their individual components. In general, the key components of DESs include a hydrogen bond acceptor (HBA) (e.g., a salt) and hydrogen bond donor (HBD) (e.g., polyols, sugars, organic acids, amides, and amino acids, that are bonded chemically via hydrogen bonds1. The hydrogen bonds result from the complexation between an HBA, usually choline chloride (ChCl), and an HBD.

Several factors -such as the interactions between the salt’s anionic species and the HBD, the lattice energies of the ionic species of the DESs, the nature and asymmetry of the organic salts, and the charge delocalization that occurs through hydrogen bonding- are responsible for the significant depression in freezing points that are experienced with DESs. The freezing point depression governs the thermal stability and easy storage of DESs, because most DESs assume liquid phases between room temperature and 70 °C2.

In addition, other attractive properties have been associated with DESs, such as their lack of flammability, low volatility, thermal and chemical stability, tuneability, wide polarity, low vapor pressure, high solvability, and affordability (low-cost starting materials)3. Although they are classified in several categories (according to the chemical nature of the HBA and HBD), the most frequently encountered DESs are prepared using the quaternary ammonium salt ChCl. Because cholinium is a known component of vitamin B complex, its use for DES preparations has led to the anticipation of safe and sustainable mixtures.

DESs have many applications in various fields, such as biotransformation4, downstream and upstream biodiesel processes5,6, extraction of bioactive substances7, drug transport and solubility8, and nanotechnology9. However, research into ChCl-based DESs has not always demonstrated negligible toxicity profiles.

Following preliminary studies, Hayyan et al.10,11 showed that quaternary ammonium salts (ChCl) are toxic to aquatic organisms (e.g., brine shrimp), whereas phosphonium salts are toxic to aquatic and terrestrial organisms (e.g., bacteria). Subsequent studies12,13,14 have concluded that the inherent toxicity of DESs depends on many factors, including the molar ratio and the chemical composition of the raw materials.

Unstable molar ratios convert relatively safe mixtures into toxic eutectics. Hayyan et al.11 reported that [ChCl]-[urea/glycerol/ethylene glycol] DESs (molar ratio of 1:3) did not inhibit E. coli growth. Conversely, at a ratio of 1:1, these mixtures were lethal to E. coli, as shown by Wen et al.14. Thus, the change in ratio most likely directly increased the viscous character of these mixtures and indirectly affected their lethality.

The chemical nature of the starting materials influences the toxicity profile of the resulting DESs. In a recent study, Zhao et al.15 recorded high inhibitory values for organic acids-based DESs, in contrast to amine-/alcohol-based DESs, which were non-inhibitory. A similar observation was made by Radošević et al.13. The authors noted the formation of harmful intracellular calcium oxalate crystals following treatment of MCF-7 cells with [ChCl]-[oxalic acid] DES, whereas amine- and alcohol-based DESs were relatively non-toxic. These results support the claim that harmless DESs can be obtained using biomaterials and renewable substances.

A subset of DESs, termed natural deep eutectic solvents (NADESs), are prepared solely using raw materials of natural origin (e.g., amino acids, sugars, and organic acids). NADESs were discovered through an analysis of metabolomic data from various plant materials. Choi et al.16 argued that inexplicably high concentrations of primary metabolites in plant cells (choline, sugars, acids, amino acids, etc.) were necessary to prepare NADESs, which amount to novel cellular media (in addition to water and lipids). The purpose of these media would include the dissolution of solutes of intermediate polarity, the storage of metabolic products, cryopreservation, germination, and resistance. A separate study17 compiled a list of potential combinations of NADESs. Despite the lack of the physicochemical characterization of NADESs, their large-scale use requires appropriate and accurate safety policies, based on toxicology assessments. The use of ChCl as the chief component of DESs implies relatively non-toxic profiles, which have yet to be encountered in vivo or in vitro. Thus, given that most NADESs are based on ChCl, critical and in-depth analyses of their toxicity profiles are needed. Only Paiva et al.18 and Zhao et al.15 have examined the toxicity of these mixtures. Although these mixtures have demonstrated excellent viability, their intracellular mechanisms have not been examined.

In this study, the cellular impact of two NADESs that were based on ChCl and the HBDs glucose and fructose was compared to that of a DES that was based on N,N-diethylethanol ammonium chloride (DAC) and triethylene glycol (TEG) in various cancer cell lines (Fig. 1). NADESs’ cytotoxic mechanism was assessed through cellular membrane porosity and redox stress analysis. Furthermore, a novel in vivo cytotoxic profile of NADESs was generated. Both NADESs were prepared using a salt-to-HBD ratio of 2:1, which is optimal ratio for these mixtures19,20,21.

Figure 1. Chemical structures of the individual components of the understudied NADESs and DES.

Figure 1

Materials and Methods

Chemicals and materials

N,N-diethylethanol ammonium chloride (≥98%), glucose, fructose (≥99%), and triethylene glycol (≥99%) were purchased from Merck. Choline chloride (≥97%) was obtained from Sigma-Aldrich. The human cervical cancer cell line (HelaS3), human prostate cancer cell line (PC3), human gastric cancer cell line (AGS), human skin malignant melanoma cell line (A375), human breast cancer cell line (MCF-7), and human hepatocyte cell line (WRL-68) were purchased from American Type Culture Collection (ATCC, Manassas, VA). Dulbecco’s Modified Eagle Medium (DMEM) and the Roswell Park Memorial Institute medium (RPMI 1640) were obtained from Life Technologies, Inc., Rockville, MD. Fetal bovine serum (FBS) was supplied by Sigma-Aldrich.

Preparation of DES

Table 1 illustrates the composition, molar ratios, and symbols of the NADESs. The preparation method was similar to that reported in the literature10,11,22. The NADESs were prepared at a 2:1 salt-to-HBD ratio, whereas the DES followed a 1:3 molar ratio. The aqueous solutions were prepared using the same concentration of each component in the DES—dissolved in distilled water individually (Gluaq, Fruaq, ChClaq, DACaq, TEGaq) or combined (e.g., ChCl + Glu = NADES1aq).

Table 1. Composition, molar ratio and appearance of the understudied DESs.

NADES Salt HBD Molar ratio (Salt/HBD) Appearance
NADES1 ChCl Fru 2:1 Moderately viscous liquid
NADES2 ChCl Glu 2:1 Moderately viscous liquid
DES1 DAC TEG 1:3 Lightly viscous liquid

Cell culture

HelaS3, A375, AGS, and WRL-68 cell lines were grown in DMEM that was supplemented with 10% FBS, 100 U/ml penicillin, and 100 μg/ml streptomycin. MCF-7 and PC3 cell lines were grown in RPMI, supplemented with 10% FBS, 100 U/ml penicillin, and 100 μg/ml streptomycin. The cells were kept in culture flasks inside an incubator that provided a humidified atmosphere of 37 °C, with 5% CO2. The cells were grown to 80% to 90% confluence, as necessary for the viability assay.

MTT viability assay

MTT cell viability assay was performed as described in the literature12. The EC50 values were obtained from an average of at least three independent experiments. The standard error of the mean (SEM) from the repeat experiments was used to derive the variations from the average EC50 values. The statistical analysis was performed using Graph Pad Prism 5. Statistical significance was defined when P ≤ 0.05.

Membrane permeability assay

A total of 1 × 104 cells per well were seeded onto a 96-well plate for 16 h. The cells were then treated with DESs at EC50 concentrations and incubated for another 24 h at 37 °C in 5% CO2. To examine plasma membrane permeability, cell permeability dye (Image-iT DEAD Green viability stain, Thermo Fisher) was added to live cells and incubated for 30 min, as described in the literature23. DEAD Green is an impermeant dye to healthy cells that becomes permeant when the plasma membrane of cells is compromised. The cells were washed twice with PBS before being fixed with 3.7% formaldehyde solution for 20 min and read on a fluorescent microplate reader at an excitation/emission wavelength of 488/515. The cells were kept overnight in PBS. The cells were visualized and the images were captured the following day using the Cellomics ArrayScan High content screening reader system (Thermo Scientific, PA, USA).

Oxidative stress assay

Reactive oxygen species (ROS) assay was carried out to determine the influence of solvents on the production of ROSs in treated cells. A total of 1 × 104 cells per well were seeded onto 96-well plate and incubated overnight at 37 °C in 5% CO2. The cells were then treated with EC50 concentrations of the solvents for 24 h, after which dihydroethidium (DHE) dye was added to the live culture for 30 min. The cells were fixed and washed with PBS as described previously24. The DHE dye probe is typically oxidized to ethidium in the presence of superoxides. The fluorescence intensity was measured on a fluorescent plate reader at an excitation wavelength of 520 nm and an emission wavelength of 620 nm. The values are expressed as means ± SD of three sets of experiments. The cells were visualized, and images were captured on the following day on a Cellomics ArrayScan HCS reader (Thermo Scientific).

In vivo assessment

The acute toxicity of the compounds was evaluated using six Imprinting Control Region (ICR) mice per group at 8 to 12 weeks of age, with an average body weight of 25.6 g. The mice were assigned equally into 4 groups: vehicle (dH2O), high-dose (20 g/kg), medium-dose (10 g/kg), and low-dose (5 g/kg). Prior to administration, the mice were fasted (but allowed to drink water) overnight and for 3 to 4 h after administration of the compounds to eliminate any residual food in the gastrointestinal tract that might have complicated absorption of the test substance.

The mice were observed at 30 min and 2, 4, 24, and 48 h after administration for the onset of clinical or toxicological symptoms and mortality and behavioral changes following treatment. They were euthanized by CO2 asphyxiation on Day 15, and serum biochemical and histological (liver and kidney) parameters were measured using standard methods. The mortality of the mice were recorded within 14 days and used to calculate the LD50 for each compound. The sampled mice were housed in a specific pathogen-free facility at the University of Malaya. This work was designed to minimize animal suffering and the number of animals that was used. The study was approved by the Faculty of Medicine Animal Care and Use Committee (FOMIACUC, Approval No: 2014-05-07/PHAR/R/CYL) at the University of Malaya and was conducted in accordance with ARRIVE guidelines.

Results and Discussion

MTT viability assay

The MTT viability assay results depict NADESs as harmful materials, based on the EC50 values in Table 2. A morphological assessment of HelasS3, AGS, MCF-7, and WRL-68 cell lines following NADES1 and NADES2 treatment also demonstrated the lethal effects of these mixtures. Figure 2 shows that under NADES1, NADES2, and DES1 treatment, MCF-7 cell lines shrink considerably, with their shapes and morphologies no longer consistent with viable growth. Cell confluence was significantly affected, and the culture media were filled with dead cells and those approaching the necrotic state. The same effects were observed for the other cancer cell lines (Figure S1, Supplementary Material).

Table 2. EC50 values of the understudied NADESs/DES across various cell lines.

Solvent EC50 (mM)
Hela S3 PC3 MCF-7 A375 AGS WRL-68
NADES1 436 ± 15 197 ± 17 102 ± 15 150 ± 28 98 ± 7.1 112 ± 7.8
NADES2 516 ± 40 340 ± 16 247 ± 8.1 265 ± 10 138 ± 14 185 ± 31
DES1 120 ± 15 116 ± 12 93 ± 18 91 ± 8.7 46 ± 0.75 34 ± 5.2

Figure 2. Light microscope images of MCF-7 cells submitted to NADESs/DES treatment.

Figure 2

Control cells shown were not subjected to any treatment, and represent the 100% growth. The other cells were treated with different concentrations (100%, 50%, and 25%) of the solvents with 100% being 4.5 M.

The EC50 values for NADES1 and NADES2 ranged from 98 to 516 mM. The only other toxicological assessment of NADES ([ChCl]-[Glu]) on cancer cells had EC50 values ≥ 10 mM in MCF-7 cells13. Following the inclusion of DES1, the range of effective concentrations widened. Despite a lower endpoint, the final range of EC50 values (34 ≤ EC50 ≤ 516 mM) remained significantly higher than those reported.

Across all cells, DES1 was the most toxic mixture (Table 2). The increase in solvent toxicity followed the same sequence between all cell lines: NADES2 < NADES1 < DES1. Cell line susceptibility varied between eutectics. For NADES1, AGS cell line was the most susceptible, whereas HelaS3 cells were the least (AGS < MCF-7 < WRL-68 < A375 < PC3 < HelaS3). For NADES2, the trend was similar with one exception: WRL-86 cells were more susceptible than the breast cancer cell line (AGS < WRL-68 < MCF-7 < A375 < PC3 < HelaS3). DES1 was more toxic to the hepatic cell line than to any other cell line (WRL-68 < AGS < A375 < MCF-7 < PC3 < HelaS3). Overall, HelaS3 and PC3 cell lines were the least harmed, whereas the eutectic mixtures were increasingly lethal to AGS and WRL-68 cell lines, demonstrating that these mixtures harm normal (i.e., WRL-68) and cancerous cells, likely through a shared process in these cells. Thus, although greener than DES, NADESs can be used as potential anticancer agents but will require targeted delivery (e.g., nanoparticles) due to the risk that is posed to normal cells.

Figure 3 displays the chemical structures of glucose and fructose, which have the same chemical formula (C6H12O6). In Table 2, NADES-based glucose (NADES2) was less toxic than its fructose (NADES1) counterpart across all cell lines. The metabolic pathways that each metabolite follows upon absorption explain this difference. Glucose and fructose are reducing sugars that represent an energy source for cells. Glucose is the primary energy source for all tissues, whereas fructose is metabolized primarily by the liver. Glucose metabolism is regulated by insulin, which determines the fate of the ingested glucose. When glucose is intended to produce energy, it enters aerobic glycolysis and is phosphorylated to glucose-6-phosphate (G-6-P) by the enzyme glucokinase (GK). G-6-P can be converted to NADH, antioxidants, nucleic acids, and uric acid via the oxidative pentose phosphate pathway (PPP); to triglycerides and lipids by de novo lipogenesis; or to energy through the tricarboxylic acid (TCA) cycle and oxidative phosphorylation (electron transport chain) (Fig. 4).

Figure 3. Glucose and fructose 3D models.

Figure 3

Figure 4. Metabolic pathway of glucose and fructose39.

Figure 4

(De Gruyter The role of fructose in metabolism and cancer, Walter De Druyter GmbH Berlin Boston (2015). Copyright and all rights reserved, Material from this publication has been used with the permission of Walter De Gruyter Gmbh.) Glucose intracellular transport occurs by means of the insulin-dependent transporter Glut4, whereas fructose enters the cell through Glut 5. Insulin directly promote glucose metabolism through glycolysis or its storage as glycogen, by controlling the transcription of glucokinase (GK). Red arrows represent pathways used by glucose. Black arrows represent pathways used by glucose but preferentially by fructose. Metabolites and enzymes. Glut: glucose transporter; KHK: ketohexokinase; ATP: adenosine triphosphate; ADP: adenosine diphosphate; AMP: adenosine monophosphate; G6P: glucose-6-phosphate; F1P: fructose-1-phosphate; F6P: fructose-6-phosphate; F1,6P2: fructose1,6 biphosphate; GA: glyceraldehyde; DHAP: dihydroxyacetone phosphate; G3P: glyceraldehyde-3-phosphate; PEP: phosphoenolpyruvate; TG: triglyceride.

Fructose processing is not controlled by insulin secretion; thus, fructose can nearly continuously enter the glycolytic pathway (via polyol conversion) and undergo de novo lipogenesis (leading to fatty acid accumulation)25. Under energy-deficient conditions, this pathway is an effective beneficial measure. However, at homeostasis, it can have disastrous intracellular effects. High-fructose diets increase the synthesis of advanced glycation end products (AGEs) faster than glucose-based diets. AGEs are obtained following glycation or through sugar intermediates that are produced during glycolysis. Glycation refers to the non-enzymatic modification of biomolecules (amino acids, lipids, nucleotides) following the addition of a sugar, in a process that is known as the Maillard reaction (Fig. 5)26. AGEs inflict serious damage to biomolecules by modifying their structure and subsequently enhancing ROS synthesis.

Figure 5. Formation of AGEs from Amadori and Heyns products of glucose and fructose, respectively.

Figure 5

Interactions of biomolecules with ROSs ultimately impair metabolic functions (Fig. 6). For instance, glycation of proteins results in biochemical dysfunction, protein crosslinks, and alteration of protein structure27. Membrane interactions can also be affected by the formation of lipid glycation adducts through increased membrane fluidity, the promotion of lipid peroxidation, and eventually oxidative damage28,29,30,31. Similarly, the effects of AGEs on DNA include strand breaks, unwinding of the double helix, mutations, and formation of DNA-protein and nucleotide-nucleotide crosslinks32,33,34. Fructose produces AGEs at least seven times faster than glucose, ultimately leading to over a 100-fold increase in ROS production compared to glucose-based AGEs. The cell is then unable to generate enough antioxidants to deal with the oxidative species35,36.

Figure 6. Formation of AGE and ROS from reducing sugars (fructose and glucose).

Figure 6

Sugars use two strategies to synthesize AGEs intracellularly. The first one is through glycolysis, and the second makes use of the Maillard reaction.

The situation is worse for cancer cells, in which upregulation of glycolysis occurs because the cells require a higher amount of carbohydrates compared with normal cells for growth, proliferation, migration, and invasion37. The higher carbohydrate requirement also stems from the fact that cancer cells initially use anaerobic glycolysis for glucose/fructose metabolism and thus produce less total energy (energy output is higher for aerobic glycolysis than anaerobic glycolysis). Accordingly, in cancer cells, high-glucose diets generate AGEs at a higher rate than normal cells, leading to oxidative damage, tissue damage, and inflammation, due to the imbalance between AGEs and intracellular antioxidants. As a result, glucose, despite being a desired cellular metabolite, becomes cytotoxic.

However, fructose is more cytotoxic, because the conversion and generation rates of AGEs and ROSs are significantly higher than those of glucose. Moreover, in cancer cells, fructose (converted to glucose intermediates via the polyol pathway; Fig. 4) is the preferred carbohydrate source for nucleic acid biosynthesis, whereas glucose is allocated primarily for glycolysis38. Fructose-based nucleic acid synthesis via the non-oxidative PPP in cancer cells stimulates an increase in uric acid synthesis39. Overproduction of uric acid following high-fructose diets is often associated with endothelial dysfunction, cardiovascular disease, and oxidative metabolism, with increased ROS concentrations and ultimately redox stress. This information is helpful in justifying the greater toxicity of NADES1 compared to NADES2.

Other factors, such as the physical properties of the eutectic mixtures, can be used to explain the difference in EC50 values. Table 3 lists the viscosity and pH of NADESs at 25 °C. Both NADESs are neutral mixtures (pH ~7), but NADES1 (11733.1 mPa.s) is more viscous than NADES2 (8045.1 mPa.s)19,20. As highly viscous materials are more toxic than less viscous compounds, it may account for the greater toxicity of NADES1.

Table 3. Viscosity and pH of DES/NADESs at 25 °C19,20.

Solvent Viscosity (mPa.s) pH
NADES1 11733.1 6.65
NADES2 8045.1 7.24

However, in general, NADES1 and NADES2 had higher viscosity and less acidity than DES1 but were less toxic, in contrast to the greater toxicity that is expected with highly viscous mixtures. Although the natural origin of the raw materials of the NADESs is one possible reason for this phenomenon, the acidity of the DES1 appears to influence this property.

According to Table 3, NADES1 and NADES2 are neutral mixtures (pH 6.67 and 7.24, respectively). The intra-cytoplasmic pH is often found in a range that approximates that of NADES2 (7.1~7.2)40, which also explains why it was the least detrimental eutectic mixture. Cancer cells often have a slightly more acidic extracellular environment due to lactate and H+ overproduction from increased glycolysis, even in the presence of oxygen (the Warburg effect)41. The ensuing extracellular acidosis (5.8~7.6 in human and rodent tumors)42 and the resulting gradient difference can be toxic to cancer cells, which appears to be the case for NADES1 and DES1.

Riemann et al.43 confirmed that induced extracellular acidosis promotes a sustained decrease in intracellular pH and the formation of ROSs. DES1 was more detrimental than NADES1, because its pH (~1) is significantly lower, and thus, the influx of H+ is higher. Hence, ROSs are generated at a higher rate compared with NADES1, causing DES1 to be more toxic than NADES1. This influx of acid into the cell also explains the higher toxicity of NADES1 versus NADES2. Moreover, the gradient difference that is created by the difference in pH contributes to the cellular absorption of ions (Na+, K+, Ca+) and metabolites that are important for cancer progression, invasion, and migration. The influx of NADES1 and NADES2 might be relevant to the cell for specific metabolic purposes, but import of DES1 differs, because DAC and triethylene glycol metabolites are not needed as much as glucose, fructose, or ChCl. Following ingestion, TEG is metabolized by alcohol dehydrogenase to yield toxic diacid and hydroxy acid compounds, which advance metabolic acidosis44,45. Thus, their presence in high amounts promotes their cytotoxicity, rendering them lethal to the cell.

As shown in Table 2, the EC50 values varied between cell lines, with the lowest value associated with AGS cell line and the highest corresponding to HelaS3 cell line. These findings suggested that a gastric cancer cell line was easily affected by DESs, whereas the opposite occured for HelaS3 cell line. Given that cells are protected and compartmentalized primarily by their membranes, their interaction with NADESs must be a crucial factor for the ensuing cellular stress.

Assessment of membrane permeability

The cell permeability assessment following NADESs treatment showed a comparable effect with the DESs that were tested by Hayyan et al.12 (Fig. 7). Using a permeability dye (Image-iT DEAD Green viability stain) as an indicator of cell membrane damage, we evaluated the severity of NADES/DES cytotoxicity. Once the dye penetrates the cytoplasm, its detection of affected or dead cells by fluorescent imaging (green) establishes the effect of the applied material.

Figure 7. Effect of NADESs/DES on the permeability of various cell lines.

Figure 7

Fluorescent images of AGS, HelaS3, MCF-7 and WRL-68 control and treated cells with EC50 concentrations of NADESs/DES.

As shown in Fig. 7, the green fluorescence of NADESs and DES is more discernible in treated cells versus the control.

In NADES-/DES-treated cells, this fluorescence stemmed from within the cells, implying increased porosity, whereas in control cells, only extracellular fluorescence of debris could be seen, suggesting that the dye did not penetrate the cells, allowing them to remain healthy. These results established the capacity of NADESs to perforate cellular membranes. However, DESs were more destructive than NADESs, based on the stronger emitted fluorescence of DES1-treated cells. The increased porosity in DES1-treated cells versus NADES1 and NADES2 might be related to the complex interactions between these mixtures and the cell membrane. The fluorescence values of each cell line before and after treatment are shown in Figure S2 (Supplementary Material).

Membranes are composed of a matrix of lipids and proteins, the structures of which regulate their permeability. The composition of membrane lipid moieties depends on the cell type and its physiological requirements and functions46. One of the most important constituent of lipid bilayers are phospholipids, the distribution of which creates a unique membrane potential that regulates membrane permeability and the diffusion of ionic and molecular species (due to the nature of their various head groups and phosphate moiety densities).

Phosphatidylcholine (choline head group) is the most abundant phospholipid in plasma membranes47. It is synthesized from choline, primarily by exogenous routes to minimize energy expenditure. Choline is pivotal in the metabolism of phosphatidylcholine and other bilayer phospholipids, such as phosphatidylserine, phosphatidylethanolamine, and sphingomyelin (Fig. 8). Thus, for normal and cancer cell lines, intracellular choline import is a crucial feature of their metabolism. Several protein families that are embedded in the membrane bilayer participate in the intracellular diffusion of choline. They consist of the polyspecific organic cation transporter (OCT) family for low-affinity facilitated diffusion, the choline transporter (CHT1) family for high-affinity Na+ -dependent transport; and the choline transporter-like (CTL1) family for intermediate-affinity Na+ -independent transport48,49. Thus, similar to glucose and fructose moieties, the diffusion of choline moieties is assisted by membrane transporters. Consequently, the entry of choline or choline-based moieties is a natural phenomenon in eukaryotic cells.

Figure 8. ChCl intracellular transport and metabolism.

Figure 8

Choline enters the cell either using low-affinity facilitated diffusion via OCT transporters; high affinity Na+-dependent transport via CHT1 transporters; or intermediate affinity Na+-independent transport via CTL1 transporters. Enzymes and metabolites. CHDH: choline dehydrogenase; CAT: choline acetyltransferase; AcCoA: acetyl-coenzyme A; CoA: coenzyme A; BADH: betaine aldehyde dehydrogenase; NAD+: nicotinamide adenine nucleotide; NADH: reduced nicotinamide adenine nucleotide; CK: choline kinase; CCT: citydylyltransferase; CTP: cytidine triphosphate; CDP: cytidine diphosphate; CPT: cytidine cholinephosphotransferase; CEPT: choline/ethanolaminephosphotransferase; DAG: diacylglycerol; CMP: cytidine monophosphate; PSS1: Phosphatidylserine synthase 1; PLD: Phospholipase D; SMS: sphingomyeline synthase; CER: ceramide; PLA: phospholipase A; AC: acyl chains; PPi: pyrophosphate.

The increased permeability of NADESs-treated cells could be an indirect consequence of the limiting uptake rate of choline species through embedded membrane transport proteins and/or the threshold concentrations of these mixtures—i.e., as the rate of choline transport in cells becomes limited50, extracellular moieties might begin to accumulate on the cell surface, thereby increasing porosity. In contrast to NADESs, DES1 species (i.e., DAC and TEG) are not indigenous to the cell or perhaps are not required in similar amounts. Hence, their intercellular diffusion is restricted. As a result, they are instead primarily retained by the cell membrane, having a more pronounced deleterious effect. Previous studies established that the accumulation of ammonium cations (at a specific threshold concentration) on cellular membranes disrupts the lipid bilayer and induces cell death51. The attractions and interactions of lipid bilayers with ionic species depend on the lipid organization and density charge, the latter of which is ultimately derived from the concentrations of acidic and basic functional groups and their average association constants with hydrogen or hydroxyl ions (all of which vary between cells)52. For instance, the colorectal cancer cell line is associated with an overall increase in the concentration of all phospholipid types at the cell membrane, including phosphatidylinositol, phosphatidylserine, phosphatidylethanolamine, and phosphatidylcholine53. This property might account for the difference in EC50 values between cancer cell lines and the normal cell line (WRL-68).

These inferences are subject to the transport modes and import of NADESs into the cell. It is pivotal to ascertain whether the cellular entry of NADESs occurs as dissociated components or as a single molecule. This mechanism can be determined by analyzing the cytotoxic values of aqueous solutions of the raw materials of NADESs and comparing them with the EC50 of the pure mixtures.

In Table 4, the EC50 values of the aqueous solutions of NADESs and their chief materials are presented. NADES1aq, (101 mM) and NADES2aq (145 mM) were the least toxic mixtures, followed by glucoseaq (58 mM), fructoseaq (49 mM), DES1aq (54 mM), ChClaq (35 mM), DACaq (37 mM), and TEGaq (13 mM). The EC50 values of pure NADES1 (98 mM), NADES2 (138 mM), and DES1 (46 mM) were in a similar range as those of their aqueous solutions (NADES1aq −101 mM and NADES2aq −145 mM). It is interesting to note that pure NADESs had significantly lower cytotoxic values than aqueous solutions of their individual elements (55 ≥ Glucoseaq ≤ 61 mM; 43 ≥ Fructoseaq ≤ 55 mM; 30 ≥ ChClaq ≤ 40 mM), suggesting that NADESs did not dissociate after crossing the cellular membrane, in contrast to the assumptions of partial or complete dissociation in the literature.

Table 4. EC50 values of aqueous solutions of NADESs/DES and their raw materials.

Solvents EC50 in AGS cell line (mM)
Fructoseaq 49 ± 6
Glucoseaq 58 ± 3
ChClaq 35 ± 5
DACaq 37 ± 8
TEGaq 13 ± 1.8
NADES1aq 101 ± 9
NADES2aq 145 ± 7
DES1aq 54 ± 2.3

Based on the intersection between the ranges of EC50 values of pure NADESs (90.9 ≥ NADES1 ≤ 105.1 mM; 124 ≥ NADES2 ≤ 152 mM) and their aqueous solutions (92 ≥ NADES1aq ≤ 110 mM; 138 ≥ NADES2aq ≤ 152 mM), we propose that following cellular adsorption, the individual aqueous chief components of DESs form pure NADES mixtures intracellularly to reduce their cytotoxic effects on the cells. Although the dilution and solubility factors of the chief ingredients in aqueous solution as well as the type of cancer cell used (in this work, AGS) might have played a significant role, the previous suggestion would help explain the different profiles between pure NADESs and individual ingredients’ aqueous solutions the similarity between pure mixtures and their aqueous solutions. This hypothesis would somewhat be consistent with Choi et al.16 concerning the synthesis of NADESs by plant cells, except that we extrapolate it to mammalian cells. This assumption is based on the premise that if dissociation had occurred prior to absorption, then aqueous solutions of the individual raw materials would dictate the threshold concentrations at which cell death was induced. However, the pure solutions of NADESs had a distinct profile compared with aqueous solutions of their individual elements.

With regard to DES1, the ranges of its aqueous solutions (51.7 ≥ DES1aq ≤ 56.3 mM) and pure mixtures (45.25 ≥ DES1 ≤ 46.75 mM) do not intersect. Moreover, the range of pure DES1 mixtures (45.25 ≥ DES1 ≤ 46.75 mM) approximates that of the aqueous solution of DAC (29 ≥ DACaq ≤ 45 mM), suggesting that DES1 dissociates in the cellular media prior to entry. The addition of water to the combination of ingredients merely reduced the toxicity of DAC, which was already determining the toxicity of the overall mixture. It can also be argued that the low EC50 values of DES1 are attributed to the lower requirements of DES1 species in AGS cells.

Assessment of redox stress

The results in this study present NADESs as architects of redox stress. Figure 9 shows the images of four treated cell lines (HelaS3, AGS, MCF-7, and WRL-68) that were stained with dihydroethidium (DHE) dye. DHE freely permeates cell membranes and is thus used to monitor superoxide production. DHE reacts with superoxide ions to form a red fluorescent product (ethidium) that intercalates into DNA (forming small red dots in the cell). Although recent studies have suggested that the end product is 2-hydroxyethidium, the result is that DHE is retained well by cells and helps detect superoxide radicals54. The oxidized form of DHE gives off red fluorescence upon DNA intercalation. As shown in Fig. 9, the distinction between control and treated cells is notable, wherein the accentuated red fluorescence is visible among NADES-/DES-treated cells. Further, the intercalated DNA-DHE was strongly visible in NADES-/DES-treated cells.

Figure 9. ROS production following NADESs/DES treatment.

Figure 9

The cells were treated at each and every time with the corresponding EC50 values of the respective cells listed in Table 2.

As expected, the fluorescence was more pronounced in cells that were treated with DES1 compared with NADESs, suggesting that DES1 stimulates the synthesis of ROS to a greater extent than NADESs (correlating with the hypothesis that NADESs are easier to deal with intracellularly) or that redox stress is merely one of the mechanisms by which eutectics induce toxicity, with NADESs operating through a disparate mode of action. Regardless of which hypothesis is correct, these NADESs are less strenuous on the cell than DESs.

In vivo analysis

In vivo profiling of NADES toxicity was performed in mice, and biochemical variables were assessed in the liver and kidneys. Table 5 shows the recorded LD50 values. With regard to the discussion on EC50 above, the increasing trend of solvent toxicity in the cell lines was as follows: NADES2 < NADES1 < DES1. During the in vivo assessment, this trend was reversed (DES1 < NADES1 < NADES2). This difference was attributed to the viscosity of these solvents, because NADESs were more viscous than the DES, and therefore were difficult to handle and might have failed to circulate properly in mice. This may have blocked and halted blood flow. The injected solvents were not diluted with water; thus, they remained just as viscous as during their preparation. Dilution with water alters the physicochemical profiles of DESs55, and can provide more manageable fluids, in terms of application and cytotoxic liability.

Table 5. LD50 values collected upon treatment of mice with the understudied NADESs/DES.

Solvent LD50 (g/mL)
NADES1 1.84
NADES2 1.24
DES1 4.46

As seen in the blood biochemical analysis in Table 6, the eutectics preferentially targeted the liver, which is the primary organ that metabolizes fructose and glucose. Thus, it is understandable that excess levels of these reducing sugars primarily injured hepatic cells. As shown in Table 6, the parameters that varied the most were all affiliated with the liver: albumin, alkaline phosphatase (ALP), aspartate transaminase (AST), and G-glutamyl transferase. The fluctuations in the concentrations of these molecules are indicative of hepatocellular injury. Notably, the serum AST levels were 363 and 282 IU/L in NADES1- and NADES2-treated animals. The AST readings were approximately 10-fold higher than the normal range (15–37 IU/L). No increase in serum alanine aminotransferase (ALT) levels was observed. The AST/ALT ratios were greater than 5:1, implying that there was muscle or heart failure in addition to liver damage.

Table 6. Biochemical analysis of blood following NADESs/DES treatment.

Clinical Chemistry NADES1 NADES2 DES1 Unit Ref. Range
Renal Function Test
Sodium 146 152 ± 5 150 ± 7 mmol/L 136 145
Potassium 9.2 9.2 ± 1.4 8.7 ± 0.7 mmol/L 3.6 5.2
Chloride 105 111 ± 7 110 ± 8 mmol/L 100 108
Carbon dioxide 26.8 22.1 ± 4 18.7 ± 4.3 mmol/L 21 30
Anion Gap 23 28 ± 1 27 ± 3 mmol/L 10 20
Urea 9.7 9.0 ± 2 8.9 ± 1.1 mmol/L 2.5 6.4
Creatinine 18 11 umol/L    
Liver Function Test
Total Protein 53 52 ± 9 51 ± 3 g/L 64 82
Albumin 14 13 ± 4 13 g/L 35 50
Globulin 39 39 ± 5 38 ± 3 g/L 23 35
Total Bilirubin 2 3 2 ± 2 umol/L 3 17
Conjugated Bilirubin <1 1 <1 umol/L 0 3
Alkaline Phosphatase (ALP) 34 37 ± 14 30 ± 19 IU/L 50 136
Alanine Aminotransferase (ALT) 70 45 ± 4 54 ± 27 IU/L 12 78
Aspartate transaminase (AST) 363 282 ± 18 349 ± 23 IU/L 15 37
G-Glutamyl Transferase <3 <3 <3 IU/L 15 85
Lipid Profile
Triglyceride 1.2 1.1 ± 0.6 0.7 ± 1.1 mmol/L <1.7
Total Cholesterol 2.0 3.1 ± .06 2.3 ± 0.9 mmol/L <5.2
HDL Cholesterol 2.01 2.85 ± 0.57 2.24 ± 0.79 mmol/L <1.1

Conclusion

DESs have proven in many cases to be superior to organic solvents and ionic liquids with regard to their low toxicity. This continues to be the case for NADESs which as a subset of DESs offer particularly interesting cytotoxic profiles that hint at their potential as anticancer agents. In this study, across all cell lines, NADESs were less toxic than the DES, most likely due to the nature of their raw materials. Based on their high cellular tolerance, the intracellular synthesis of NADESs must be examined thoroughly to understand their functions. In terms of mechanism, the increasing influx of oxidant species does not appear to be the sole pathway by which NADESs effect cellular necrosis. Nevertheless, in vivo, the higher toxicity of NADESs relative to the DES is attributed to their viscosity and overall threshold concentrations, which are often lethal. Designing materials with lower viscosity might help mitigate this issue. Further studies are needed to understanding this process in depth and could lead to the selection and design of less toxic mixtures in which can be used as a potential tool for drug delivery systems.

Additional Information

How to cite this article: Mbous, Y. P. et al. Unraveling the cytotoxicity and metabolic pathways of binary natural deep eutectic solvent systems. Sci. Rep. 7, 41257; doi: 10.1038/srep41257 (2017).

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Material

Supplementary Figures
srep41257-s1.doc (733.5KB, doc)

Acknowledgments

The authors would like to express their gratitude to the University of Malaya HIR-MOHE (D000003-16001) and to UMRG (RP037B-15AET) for the financial support throughout this research.

Footnotes

The authors declare no competing financial interests.

Author Contributions M.H. conceived of the study. Y.P.M. conducted the experiments. Y.P.M., M.H., C.Y.L., and W.F.W. analyzed the data. Y.P.M., M.H., C.Y.L., W.F.W., and M.A.H. participated in the interpretation of results. Y.P.M., M.H., and W.F.W. wrote the manuscript. All authors read and approved the final manuscript.

References

  1. Smith E. L., Abbott A. P. & Ryder K. S. Deep eutectic solvents (DES) and their applications. Chem. Rev. 114, 11060–11082 (2014). [DOI] [PubMed] [Google Scholar]
  2. Zhang Q., Vigier K. D. O., Royer S. & Jerome F. Deep eutectic solvents: Syntheses, properties and applications. Chem. Soc. Rev. 41, 7108–7146 (2012). [DOI] [PubMed] [Google Scholar]
  3. Tang B. & Row K. H. Recent developments in deep eutectic solvents in chemical sciences. Monatsh. Chem. - Chem. Mon. 144, 1427–1454 (2013). [Google Scholar]
  4. Durand E. et al. Evaluation of deep eutectic solvents as new media for Candida antarctica B lipase catalyzed reactions. Process Biochem. 47, 2081–2089 (2012). [Google Scholar]
  5. Hayyan M., Mjalli F. S., Hashim M. A. & AlNashef I. M. A novel technique for separating glycerine from palm oil-based biodiesel using ionic liquids. Fuel Process. Technol. 91, 116–120 (2010). [Google Scholar]
  6. Hayyan A., Hashim M. A., Hayyan M., Mjalli F. S. & AlNashef I. M. A new processing route for cleaner production of biodiesel fuel using a choline chloride based deep eutectic solvent. J. Clean. Prod. 65, 246–251 (2014). [Google Scholar]
  7. Wei Z.-F. et al. Fast and green extraction and separation of main bioactive flavonoids from Radix Scutellariae. Ind. Crop. Prod. 63, 175–181 (2015). [Google Scholar]
  8. Sanchez-Leija R. J. J., Pojman A., Luna-Barcenas G. & Mota-Morales J. D. Controlled release of lidocaine hydrochloride from polymerized drug-based deep-eutectic solvents. J. Mater. Chem. B 2, 7495–7501 (2014). [DOI] [PubMed] [Google Scholar]
  9. Wagle D. V., Zhao H. & Baker G. A. Deep eutectic solvents: Sustainable media for nanoscale and functional materials. Acc.Chem. Res. 47, 2299−2308 (2014). [DOI] [PubMed] [Google Scholar]
  10. Hayyan M. et al. Assessment of cytotoxicity and toxicity for phosphonium-based deep eutectic solvents. Chemosphere 93, 455–459 (2013). [DOI] [PubMed] [Google Scholar]
  11. Hayyan M. et al. Are deep eutectic solvents benign or toxic? Chemosphere 90, 2193–2195 (2013). [DOI] [PubMed] [Google Scholar]
  12. Hayyan M., Looi C. Y., Hayyan A., Wong W. F. & Hashim M. A. In vitro and in vivo toxicity profiling of ammonium-based deep eutectic solvents. PLoS One 10, e0117934 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Radošević K. et al. Evaluation of toxicity and biodegradability of choline chloride based deep eutectic solvents. Ecotoxicol. Environ. Saf. 112, 46–53 (2015). [DOI] [PubMed] [Google Scholar]
  14. Wen Q., Chen J.-X., Tang Y.-L., Wang J. & Yang Z. Assessing the toxicity and biodegradability of deep eutectic solvents. Chemosphere 132, 63–69 (2015). [DOI] [PubMed] [Google Scholar]
  15. Zhao B.-Y. et al. Biocompatible deep eutectic solvents based on choline chloride: Characterization and application to the extraction of rutin from Sophora japonica. ACS Sustain. Chem. Eng. 3, 2746–2755 (2015). [Google Scholar]
  16. Choi Y. H. et al. Are natural deep eutectic solvents the missing link in understanding cellular metabolism and physiology? Plant Physiol. 156, 1701–1705 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Dai Y., van Spronsen J., Witkamp G.-J., Verpoorte R. & Choi Y. H. Natural deep eutectic solvents as new potential media for green technology. Anal. Chim. Acta 766, 61–68 (2013). [DOI] [PubMed] [Google Scholar]
  18. Paiva A. et al. Natural deep eutectic solvents-Solvents for the 21st century. ACS Sustain. Chem. Eng. 2, 1063–1071 (2014). [Google Scholar]
  19. Hayyan A. et al. Fruit sugar-based deep eutectic solvents and their physical properties. Thermochim. Acta 541, 70–75 (2012). [Google Scholar]
  20. Hayyan A. et al. Glucose-based deep eutectic solvents: Physical properties. J. Mol. Liq. 178, 137–141 (2013). [Google Scholar]
  21. Juneidi I., Hayyan M. & Mohd Ali O. Toxicity profile of choline chloride-based deep eutectic solvents for fungi and Cyprinus carpio fish. Environ Sci Pollut Res 23, 7648–7659 (2016). [DOI] [PubMed] [Google Scholar]
  22. Hayyan M. et al. Natural deep eutectic solvents: Cytotoxic profile. SpringerPlus 5, 913 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Looi C. et al. Induction of apoptosis in melanoma A375 cells by a chloroform fraction of Centratherum anthelminticum (L.) seeds involves NF-kappaB, p53 and Bcl-2-controlled mitochondrial signaling pathways. BMC Complement Altern Med 13, 1–14 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Liew S. Y. et al. Subditine, a new monoterpenoid indole alkaloid from bark of Nauclea subdita (Korth.) Steud. induces apoptosis in human prostate cancer cells. PLoS ONE 9, e87286 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Ludwig D. S. Examining the health effects of fructose. JAMA 310, 33–34 (2013). [DOI] [PubMed] [Google Scholar]
  26. Helou C. et al. Microorganisms and Maillard reaction products: A review of the literature and recent findings. Amino Acids 46, 267–277 (2013). [DOI] [PubMed] [Google Scholar]
  27. Pun P. B. L. & Murphy M. P. Pathological significance of mitochondrial glycation. Int. J. Cell Biol. 2012, 1–13 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Bucala R., Makita Z., Koschinsky T., Cerami A. & Vlassara H. Lipid advanced glycosylation: Pathway for lipid oxidation in vivo. P. Natl. Acad. Sci. 90, 6434–6438 (1993). [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Ravandi A. et al. Isolation and identification of glycated aminophospholipids from red cells and plasma of diabetic blood. FEBS Lett. 381, 77–81 (1996). [DOI] [PubMed] [Google Scholar]
  30. Requena J. R. et al. Carboxymethylethanolamine, a biomarker of phospholipid modification during the maillard reaction in vivo. J. Biol. Chem. 272, 17473–17479 (1997). [DOI] [PubMed] [Google Scholar]
  31. Oak J.-H., Nakagawa K. & Miyazawa T. Synthetically prepared Amadori-glycated phosphatidylethanolamine can trigger lipid peroxidation via free radical reactions. FEBS Lett. 481, 26–30 (2000). [DOI] [PubMed] [Google Scholar]
  32. Kasai H., Iwamoto-Tanaka N. & Fukada S. DNA modifications by the mutagen glyoxal: Adduction to G and C, deamination of C and GC and GA cross-linking. Carcinogenesis 19, 1459–1465 (1998). [DOI] [PubMed] [Google Scholar]
  33. Pischetsrieder M., Seidel W., Münch G. & Schinzel R. N 2-(1-Carboxyethyl) deoxyguanosine, a nonenzymatic glycation adduct of DNA, induces single-strand breaks and increases mutation frequencies. Biochem. Biophys. Res. Commun. 264, 544–549 (1999). [DOI] [PubMed] [Google Scholar]
  34. Chen H.-J. C. & Chen Y.-C. Analysis of glyoxal-induced DNA cross-links by capillary liquid chromatography nanospray ionization tandem mass spectrometry. Chem. Res. Toxicol. 22, 1334–1341 (2009). [DOI] [PubMed] [Google Scholar]
  35. Bose T. & Chakraborti A. S. Fructose-induced structural and functional modifications of hemoglobin: Implication for oxidative stress in diabetes mellitus. Biochim. Biophys. Acta (BBA) - General Subjects 1780, 800–808 (2008). [DOI] [PubMed] [Google Scholar]
  36. Bunn H. F. & Higgins P. J. Reaction of monosaccharides with proteins: Possible evolutionary significance. Science 213, 222–224 (1981). [DOI] [PubMed] [Google Scholar]
  37. Liu H. & Heaney A. P. Refined fructose and cancer. Expert Opin. Ther. Targets 15, 1049–1059 (2011). [DOI] [PubMed] [Google Scholar]
  38. Liu H. et al. Fructose induces transketolase flux to promote pancreatic cancer growth. Cancer Res. 70, 6368–6376 (2010). [DOI] [PubMed] [Google Scholar]
  39. Charrez B., Qiao L. & Hebbard L. The role of fructose in metabolism and cancer. Horm. Mol. Biol. Clin. Investig. 22, 79–89 (2015). [DOI] [PubMed] [Google Scholar]
  40. Damaghi M., Wojtkowiak J. W. & Gillies R. J. pH sensing and regulation in cancer. Front. Physiol. 4, 370 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Wu W. & Zhao S. Metabolic changes in cancer: Beyond the Warburg effect. Acta Biochim. Biophys. Sinica 45, 18–26 (2013). [DOI] [PubMed] [Google Scholar]
  42. Wike-Hooley J. L., Haveman J. & Reinhold H. S. The relevance of tumour pH to the treatment of malignant disease. Radiother. Oncol. 2, 343–366 (1984). [DOI] [PubMed] [Google Scholar]
  43. Riemann A. et al. Acidic environment leads to ROS-induced MAPK signaling in cancer cells. PLoS One 6, e22445 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Herold D. A., Keil K. & Bruns D. E. Oxidation of polyethylene glycols by alcohol dehydrogenase. Biochem. Pharmacol. 38, 73–76 (1989). [DOI] [PubMed] [Google Scholar]
  45. McKennis H. et al. The excretion and metabolism of triethylene glycol. Toxicol. Appl. Pharmacol. 4, 411–431 (1962). [Google Scholar]
  46. Escribá P. V. et al. Membranes: A meeting point for lipids, proteins and therapies. J. Cell. Mol. Med. 12, 829–875 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Szachowicz-Petelska B., Dobrzyńska I., Sulkowski S. & Figaszewski Z. A. In Colorectal Cancer Biology-From Genes to Tumor (ed. Dr. Rajun or Ettarh) (InTech, 2012).
  48. Michel V., Yuan Z., Ramsubir S. & Bakovic M. Choline transport for phospholipid synthesis. Exp. Biol. Med. 231, 490–504 (2006). [DOI] [PubMed] [Google Scholar]
  49. Fagone P. & Jackowski S. Phosphatidylcholine and the CDP–choline cycle. BBA-Mol Cell Biol L 1831, 523–532 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Plagemaen P. G. Choline metabolism and membrane formation in rat hepatoma cells grown in suspension culture. III. Choline transport and uptake by simple diffusion and lack of direct exchange with phosphatidylcholine. J. Lipid Res. 12, 715–724 (1971). [PubMed] [Google Scholar]
  51. Gal N. et al. Membrane interactions of ionic liquids: Possible determinants for biological activity and toxicity. Biochim. Biophys. Acta 1818, 2967–2974 (2012). [DOI] [PubMed] [Google Scholar]
  52. Dobrzynska I., Skrzydlewska E. & Figaszewski Z. Parameters characterizing acid–base equilibria between cell membrane and solution and their application to monitoring the effect of various factors on the membrane. Bioelectrochemistry 69, 142–147 (2006). [DOI] [PubMed] [Google Scholar]
  53. Szachowicz-Petelska B., Dobrzyńska I., Sulkowski S. & Figaszewski Z. A. in From Genes to Tumor (ed Dr. Rajunor Ettarh) Ch. 11, (InTech, 2012).
  54. Owusu-Ansah E., Yavari A. & Banerjee U. A protocol for in vivo detection of Reactive oxygen species. Protocol Exchange doi: 10.1038/nprot.2008.2 (2008). [DOI] [Google Scholar]
  55. Dai Y., Witkamp G.-J., Verpoorte R. & Choi Y. H. Tailoring properties of natural deep eutectic solvents with water to facilitate their applications. Food Chem. 187, 14–19 (2015). [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Figures
srep41257-s1.doc (733.5KB, doc)

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES